-

BrainCheck Achieves HITRUST i1 Certification, Demonstrating Commitment to Cybersecurity and Information Protection

HITRUST Certification validates that BrainCheck is meeting rigorous cybersecurity and data protection standards through independent assessment and assurance.

AUSTIN, Texas--(BUSINESS WIRE)--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, today announced that its BrainCheck Platform, hosted on Amazon Web Services (AWS), has earned HITRUST CSF Certified status for cybersecurity and information protection.

“Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.” – Bassel Samman, BrainCheck CTO

Share

The HITRUST Certification demonstrates that the BrainCheck Platform has met requirements defined by leading cybersecurity and regulatory frameworks, confirming that strong controls are in place to protect sensitive data and manage risk effectively.

Built on the HITRUST Assurance Program, this achievement reflects independent third-party testing, centralized quality assurance, and certification backed by HITRUST’s Cyber Threat-Adaptive engine. These elements ensure continuous alignment with the latest threat intelligence and evolving standards across NIST, ISO, and OWASP.

“As cybersecurity expectations rise, our stakeholders expect credible, validated assurance,” said Bassel Samman, CTO at BrainCheck. “Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.”

“Earning HITRUST Certification demonstrates BrainCheck’s commitment to managing information risk and protecting sensitive data through a rigorous, proven assurance process,” said Gregory Webb, CEO of HITRUST. “This achievement reflects the organization’s proactive approach to cybersecurity and trust.”

To learn more, visit www.braincheck.com.

About BrainCheck

BrainCheck is an FDA Class II–cleared digital platform for cognitive assessment and care, used by over 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic. Clinicians use BrainCheck’s validated screeners and care planning tools to create tailored protocols, completing more than 400,000 cognitive assessments to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

BrainCheck


Release Versions

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

Social Media Profiles
More News From BrainCheck

BrainCheck Announces 2025 Award Winners, Honoring Leaders Advancing the Future of Cognitive Care

AUSTIN, Texas--(BUSINESS WIRE)--BrainCheck, the leading digital cognitive assessment and care platform, today announced the winners of its inaugural 2025 BrainCheck Awards, honoring the healthcare professionals, researchers, and organizations setting new standards in cognitive care nationwide. The BrainCheck Awards celebrate exceptional individuals and practices whose work exemplifies innovation, clinical excellence, and an unwavering commitment to advancing cognitive health. These leaders stan...

BrainCheck Opens New York City Office to Support Northeast Growth

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck, a leading digital cognitive assessment and care platform, today announced the opening of its new East Coast office at 325 Hudson Street in New York City. The New York office will serve as BrainCheck’s Northeast hub, supporting growing demand from health systems, academic medical centers, specialty practices, and research organizations across the region. The expansion reflects continued momentum as healthcare organizations increasingly adopt...

BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care

AUSTIN, Texas--(BUSINESS WIRE)--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to develop and evaluate BrainCheck eConsult, an innovative web-based platform that connects primary care providers (PCPs) with dementia specialists to improve the diagnosis and management of cognitive impairment. The project aims to close the gap between screening and special...
Back to Newsroom